Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Inessa Schwab"'
Autor:
Verena Isabell Leussink, Manda Jankovic, Marie Groth, Katrin Schuh, Inessa Schwab Sauerbeck, Olaf Hoffmann
Publikováno v:
Brain and Behavior, Vol 14, Iss 6, Pp n/a-n/a (2024)
Abstract Background The revised Lublin classification offers a framework for categorizing multiple sclerosis (MS) according to the clinical course and imaging results. Diagnosis of secondary progressive MS (SPMS) is often delayed by a period of uncer
Externí odkaz:
https://doaj.org/article/954ea2297b7c425db81391a2d0ef1a74
Autor:
Francesco Menzella, MD, Jocelyne Just, MD, PhD, HDR, Inessa Schwab Sauerbeck, PhD, Claudia Mailaender, PhD, Fabiana Saccheri, PhD, Celine Thonnelier, Pharm D, Xavier Jaumont, MD, Laurence Mala, Pharm D
Publikováno v:
World Allergy Organization Journal, Vol 16, Iss 6, Pp 100787- (2023)
Immunoglobulin E (IgE) plays a critical role in the allergen-initiated inflammatory pathway and thus serves as a viable therapeutic target in allergic or IgE-mediated diseases such as asthma. Omalizumab, an anti-IgE biologic, has been approved in the
Externí odkaz:
https://doaj.org/article/1ee3faee6f3546769426d58a00e6db64
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 16, Iss 1, Pp 1-6 (2020)
Abstract Background This differential diagnosis of allergic vs non-allergic asthma is typically made on the basis of sensitization to allergens, such that absence of sensitization could result in a patient being managed as having non-allergic asthma.
Externí odkaz:
https://doaj.org/article/72a13e688c624d4cb2945ac4cc06600b
Publikováno v:
Cell Reports, Vol 13, Iss 3, Pp 610-620 (2015)
Immunoglobulin G (IgG) antibodies are major drivers of autoimmune pathology, but they are also used in the form of intravenous IgG (IVIg) therapy to suppress autoantibody activity. To identify the pathways underlying human autoantibody and IVIg activ
Externí odkaz:
https://doaj.org/article/b93f2610da2b40a3a73e8f64bc13f7d1
Autor:
Anja Lux, Michaela Seeling, Anne Baerenwaldt, Birgit Lehmann, Inessa Schwab, Roland Repp, Norbert Meidenbauer, Andreas Mackensen, Arndt Hartmann, Gordon Heidkamp, Diana Dudziak, Falk Nimmerjahn
Publikováno v:
Cell Reports, Vol 7, Iss 1, Pp 236-248 (2014)
Genetic differences between humans and in vivo model systems, including mice and nonhuman primates, make it difficult to predict the efficacy of immunoglobulin G (IgG) activity in humans and understand the molecular and cellular mechanisms underlying
Externí odkaz:
https://doaj.org/article/36dfe42316c14b8aa11600d77db51bfd
Autor:
Menzella, Francesco, Just, Jocelyne, Sauerbeck, Inessa Schwab, Mailaender, Claudia, Saccheri, Fabiana, Thonnelier, Celine, Jaumont, Xavier, Mala, Laurence
Publikováno v:
In World Allergy Organization Journal June 2023 16(6)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
In Respiratory Medicine January 2021 176
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Advances in Therapy. 37:353-363
Allergic asthma is a chronic inflammatory disease caused by immunoglobulin E (IgE)-mediated allergy. Omalizumab is a monoclonal anti-IgE antibody for the treatment of severe allergic asthma (SAA). The primary objective of the study was to assess asth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9aec75322c05e8a166aefe5d13768b3
https://doi.org/10.1007/s12325-019-01135-w
https://doi.org/10.1007/s12325-019-01135-w